Cost savings implemented & inventory replenishment completed
Filed with ASX · · 2 pages · English
Hydration solutions company The Hydration Pharmaceuticals Company Limited (ASX: HPC) (“Hydralyte USA” or “the Company”) is pleased to provide the following update on the implementation of cost saving initiatives, as well as the completion of key inventory replenishments to satisfy sales demand for previously out-of-stock products. The Company advises that Ms Margaret Hardin has tendered her resign
Hydration Pharmaceuticals Company Limited on 6ix
Earlier from Hydration Pharmaceuticals
- Q4 FY25 Quarterly Activities Report (App 4C)
- Q3 FY25 Quarterly Activities Report (App 4C)
- Q3 CY25 Sales Update and Product Launch
- Appendix 4D and FY25 Half Year Financial Report
- Q2 FY25 Quarterly Activities Report (App 4C)
Later from Hydration Pharmaceuticals
- Appendix 4E and Annual Report
- Q1 FY26 Quarterly Activities Report (App 4C)
- Capital raising, board renewal and management changes
- Q2 FY26 Quarterly Activities Report (App 4C)
- Appendix 4D and FY26 Half Year Financial Report
Follow Hydration Pharmaceuticals into a list and get an email when it puts out news.
Follow Hydration Pharmaceuticals